{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:24:11Z","timestamp":1780482251230,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ijpharm.2010.08.047","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T08:25:55Z","timestamp":1283847955000},"page":"145-152","source":"Crossref","is-referenced-by-count":13,"title":["Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia"],"prefix":"10.1016","volume":"400","author":[{"given":"Kwan Hyung","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Heok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Soon","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2010.08.047_bib0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/00365529409090447","article-title":"The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population","volume":"29","author":"Agreus","year":"1994","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1081\/PDT-100101368","article-title":"Effect of different acids on solid-state stability of an ester prodrug of a IIb\/IIIa glycoprotein receptor antagonist","volume":"4","author":"Badaway","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2005.08.004","article-title":"Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen","volume":"108","author":"Cao","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jps.2600510204","article-title":"Discoloration of tablets containing amines and lactose","volume":"51","author":"Castello","year":"1962","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(97)00385-2","article-title":"In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability","volume":"165","author":"Choi","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"US householder survey of functional gastrointestinal disorders","volume":"38","author":"Drossman","year":"1993","journal-title":"Digest. Dis. Sci."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0731-7085(03)00285-1","article-title":"Spectrophotometric and liquid chromatographic determination of trimebutine maleate in the presence of its degradation products","volume":"33","author":"El-Gindy","year":"2003","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0040","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10915810305091","article-title":"Animal drug human food safety toxicology and antimicrobial resistance\u2014the square peg","volume":"22","author":"Greenlees","year":"2003","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0050","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639049409038365","article-title":"Controlled-release matrix of acetaminophen\u2013ethylcellulose solid dispersion","volume":"20","author":"Hernandez","year":"1994","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0055","unstructured":"ICH Q3B (R2), 2006. Impurities of new drug products. http:\/\/www.ich.org\/cache\/compo\/276-254-1.html."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-4347(98)00516-7","article-title":"High-performance liquid chlromatographic determination of trimebutine and its major metabolite, N-monodesmethyl trimebutine, in rat and human plasma","volume":"723","author":"Joo","year":"1999","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2116\/analsci.18.1269","article-title":"The determination of mosapride citrate in bulk drug samples and pharmaceutical dosage forms using HPLC","volume":"18","author":"Krishnaiah","year":"2002","journal-title":"Anal. Sci."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-4274(01)00481-7","article-title":"Threshold of toxicological concern (TTC) in food safety assessment","volume":"127","author":"Kroes","year":"2002","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.ijpharm.2010.08.047_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1248\/bpb.33.279","article-title":"Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium","volume":"33","author":"Li","year":"2010","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ijpharm.2010.08.047_bib0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1185\/03007998009109464","article-title":"A three-part controlled study of trimebutine in the treatment of irritable colon syndrome","volume":"6","author":"L\u00fcttecke","year":"1980","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/03639040500306187","article-title":"The hygroscopicity of moisture barrier film coatings","volume":"31","author":"Mwesigwa","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0090","first-page":"415","article-title":"Studies on the stability of trimebutine maleate in aqueous solution","volume":"34","author":"Park","year":"1990","journal-title":"Yakhak Hoeji"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(03)00387-9","article-title":"The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets","volume":"264","author":"Patel","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0100","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2003"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2036.1998.00268.x","article-title":"The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease","volume":"12","author":"Ruth","year":"1998","journal-title":"Aliment. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0110","first-page":"867","article-title":"Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects","volume":"43","author":"Sakashita","year":"1993","journal-title":"Arzneimittel-Forsch."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0115","unstructured":"Society of Toxicology (SOT), 2008. Guiding principles in the use of animals in toxicology. www.toxicology.org\/AI\/FA\/guidingprinciples.pdf."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1992.tb00050.x","article-title":"Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications","volume":"6","author":"Talley","year":"1992","journal-title":"Aliment. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/00365528509088842","article-title":"The association between non-ulcer dyspepsia and other gastrointestinal disorders","volume":"20","author":"Talley","year":"1985","journal-title":"Scand. J. Gastr."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0130","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","article-title":"Dyspepsia and dyspepsia subgroups: a population-based study","volume":"102","author":"Talley","year":"1992","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2010.08.047_bib0135","first-page":"1137","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0140","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0016-5085(91)90395-2","article-title":"Dual effect of trimebutine on contractility of the guinea pig ileum via the opioid receptors","volume":"101","author":"Taniyama","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2008.06.025","article-title":"Chemical stability and bioadhesive properties of an ester prodrug of \u03949-tetrahydrocannabinol in poly (ethylene oxide) matrices: effect of formulation additives","volume":"362","author":"Thumma","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.08.047_bib0150","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1002\/jps.21779","article-title":"Miscibility\/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems","volume":"98","author":"Yoo","year":"2009","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310006770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310006770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T06:51:43Z","timestamp":1544251903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517310006770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0378517310006770"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2010.08.047","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}